CURCUMA AERUGINOSA ROXB. EXTRACT INHIBITS THE PRODUCTION OF PROINFLAMMATORY CYTOKINES ON RAW 264.7 MACROPHAGES

Objective: The study explores the potential of Curcuma aeruginosa Roxb. extract for anti-inflammatory properties. Methods: Curcuma aeruginosa Roxb. simplicia was macerated with distilled ethanol. In vitro testing was done on Raw 264.7 macrophages to fulfill this aim by observing Tumor Necrosis Facto...

Full description

Bibliographic Details
Published in:International Journal of Applied Pharmaceutics
Main Author: Dewi I.P.; Dachriyanus; Aldi Y.; Ismail N.H.; Hefni D.; Susanti M.; Syafri S.; Wahyuni F.S.
Format: Article
Language:English
Published: Innovare Academics Sciences Pvt. Ltd 2024
Online Access:https://www.scopus.com/inward/record.uri?eid=2-s2.0-85190956205&doi=10.22159%2fijap.2024.v16s1.08&partnerID=40&md5=a9ae83ac0223e287b665a840098fea81
Description
Summary:Objective: The study explores the potential of Curcuma aeruginosa Roxb. extract for anti-inflammatory properties. Methods: Curcuma aeruginosa Roxb. simplicia was macerated with distilled ethanol. In vitro testing was done on Raw 264.7 macrophages to fulfill this aim by observing Tumor Necrosis Factor (TNF)-α, Interleukin (IL)-6 production and phagocytosis activity. The production of IL-6 and TNF-α were determined using the ELISA method while phagocytosis activity using the neutral red uptake method. Results: The results showed that Curcuma aeruginosa Roxb. extract inhibited production of TNF-α and IL-6 and phagocytic activity and on Raw 264.7 macrophages. Conclusion: The results demonstrated that Curcuma aeruginosa Roxb. extract could be developed as an anti-inflammatory, which can be improved as a novel pharmaceutical approach for treating inflammation-related illness. © 2024 The Authors. Published by Innovare Academic Sciences Pvt Ltd.
ISSN:9757058
DOI:10.22159/ijap.2024.v16s1.08